NCT06551246View on ClinicalTrials.gov

Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children with Daytime Urinary Incontinence (BeDry)

PHASE3RecruitingINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Urinary Incontinence in Children
Interventions
DRUG

Solifenacin

According to randomization.

DRUG

Mirabegron

According to randomization.

Trial Locations (5)

6000

RECRUITING

Department of Pediatric and Adolescent Medicine, Kolding Hospital, Kolding

6700

RECRUITING

Department of Pediatric and Adolescent medicine, Esbjerg Hospital, Esbjerg

7400

RECRUITING

Department of Pediatric and Adolescent Medicine, Gødstrup Hospital, Herning

8200

RECRUITING

Department of Pediatric and Adolescent Medicine, Aarhus University Hospital, Aarhus

9000

RECRUITING

Department of Pediatric and Adolescent Medicine, Aalborg University Hospital, Aalborg

All Listed Sponsors
lead

University of Aarhus

OTHER